# CairnSurgical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cairnsurgical

- Industry: Medical Devices & Equipment
- Headquarters: Lebanon, US
- Website: www.cairnsurgical.com/
- Total disclosed funding: $7.8M
- Latest round: Series A (Aug 21, 2024)
- Investors on record: 1

## About

Based in New Hampshire, US, and founded in 2015 by co-founders Venkat Krishnaswamy, Ph.D., Keith Paulsen, and Richard Barth, CairnSurgical, Inc. operates as a developer of 3D printing technology for breast cancer patients, using patient imaging data to create surgical guides that are unique to each patient. In August 2024, CairnSurgical, Inc. raised USD 4.5 million in Series A funding led by Morningside Group. As of 2024, the company is led by its CEO, David Danielsen.

The company provides a wide range of surgical guidance solutions, such as the Breast Cancer Locator (BCL), which is a 3D-printed, patient-specific surgical guide. The BCL uses MRI data to assist in precise tumor localization and removal by offering information on tumor size, shape, and margins. Additionally, the firm also provides services such as clinical trials and imaging data analysis to improve the accuracy of breast cancer surgeries.

The company plans to use its proceeds from August 2024 funding to complete the ongoing U.S. pivotal trial of the Breast Cancer Locator (BCL) system and launch its product in selected European markets.

## Funding rounds

- Series A, Aug 21, 2024, $4.5M — 5Y Capital
- Series A, Dec 4, 2019, $3.3M — 5Y Capital

## Investors

- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series A